Moderna, Inc.
Status: Publicly traded
Direct answer
Moderna, Inc. is publicly traded on NASDAQ under the ticker MRNA.
Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States,...
Can you invest in Moderna, Inc.?
Yes. Moderna, Inc. is publicly traded on NASDAQ under the ticker MRNA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Moderna, Inc.
Detailed equity research is provided by MarketSnap.